EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review

Viviana Nociti iD, Marina Romozzi

Journal of Personalized Medicine · 24.10.2023 · 13 (11) · 1524

DOI: 10.3390/jpm13111524 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 24.10.2023. Verfasst von Viviana Nociti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centro Sclerosi Multipla, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a chronic, inflammatory, degenerative demyelinating disease of the central nervous system (CNS) of unknown etiology that affects individuals in their early adulthood. In the last decade, life expectancy for people with MS (PwMS) has almost equaled that of the general population. This demographic shift necessitates a heightened awareness of comorbidities, especially the ones that can be prevented and modified, that can significantly impact disease progression and management. Vascular comorbidities are of particular interest as they are mostly modifiable health states, along with voluntary behaviors, such as smoking and alcohol consumption, commonly observed among individuals with MS. Vascular risk factors have also been implicated in the etiology of cerebral small vessel disease. Furthermore, differentiating between vascular and MS lesion load poses a significant challenge due to overlapping clinical and radiological features. This review describes the current evidence regarding the range of preventable and modifiable comorbidities and risk factors and their implications for PwMS.

Schlagwörter

Stichwörter der Autor:innen

MScomorbiditiesdisease-modifying therapiespersonalized medicine

Autor:innen und Institutionen

  • Centro Sclerosi Multipla, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
  • Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

ORCID-Profile: Viviana Nociti

Zitieren

APA

Nociti, V., & Romozzi, M. (2023). The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review. Journal of Personalized Medicine, 13(11), 1524. https://doi.org/10.3390/jpm13111524

Vancouver

Nociti V, Romozzi M. The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review. Journal of Personalized Medicine. 2023;13(11):1524. doi:10.3390/jpm13111524

BibTeX
@article{Nociti2023,
  author = {Nociti, Viviana and Romozzi, Marina},
  title = {The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review},
  journal = {Journal of Personalized Medicine},
  year = {2023},
  volume = {13},
  number = {11},
  pages = {1524},
  doi = {10.3390/jpm13111524}
}
Kostenlos starten →